The Fed. Circ. In April: Hurdles Remain For Generics
This article is part of a monthly column that highlights an important patent appeal from the previous month. In this installment, we examine the Federal Circuit's recent ruling in Salix Pharmaceuticals v....To view the full article, register now.
Already a subscriber? Click here to view full article